// App-Quantinova.ai

P470 : Comparative effectiveness analysis of flares, hospitalisations, and corticosteroid use among biologic naïve patients with inflammatory bowel disease within 12 months of initiation of vedolizumab or infliximab

Researchers

Presenter

  • N. Alam

Principal Investigators

  • M. Raluy-Callado

  • B. Gardstein

  • R. Curtis

  • J.M. Khalid

Medical Centers

  • Evidera, Inc., London, United Kingdom

  • Evidera, Waltham, MA, United States

  • Takeda Development Centre London United Kingdom

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

  • Infectious Diseases (ID)

  • Genetic Disorder

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Entyvio

  • Infliximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved